Skip to main content

Peer Review reports

From: Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Original Submission
16 Mar 2020 Submitted Original manuscript
9 Apr 2020 Author responded Author comments - Robert Olson
13 Apr 2020 Author responded Author comments - Robert Olson
Resubmission - Version 2
9 Apr 2020 Submitted Manuscript version 2
15 Apr 2020 Author responded Author comments - Robert Olson
Resubmission - Version 3
15 Apr 2020 Submitted Manuscript version 3
Publishing
16 Apr 2020 Editorially accepted
5 May 2020 Article published 10.1186/s12885-020-06876-4

You can find further information about peer review here.

Back to article page